Fenretinide in Healthy Young Women at Genetic and Familial Risk
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: High-Risk Cancer
Interventions: DRUG: Fenretinide|OTHER: Placebo
Sponsor: European Institute of Oncology